Author(s): Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW,
Abstract Share this page
Abstract The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000 patients from 158 participating hospitals. Trends in device strategy, patient profile at implant and survival are presented. Risk factors for mortality with continuous-flow pumps are updated, and the major causes/modes of death are presented. The adverse event burden is compared between eras, and health-related quality of life is reviewed. A detailed analysis of outcomes after mechanical circulatory support for ambulatory heart failure is presented. Recent summary data from PediMACS and MedaMACS is included. With the current continuous-flow devices, survival at 1 and 2 years is 80\% and 70\%, respectively. Copyright © 2015 International Society for Heart and Lung Transplantation. All rights reserved.
This article was published in J Heart Lung Transplant
and referenced in Journal of Cardiovascular Diseases & Diagnosis